A Study to Evaluate and Compare the Efficacy and Safety of Alectinib Versus Crizotinib and to Evaluate the Pharmacokinetics of Alectinib in Asian Participants With Treatment-Naive Anaplastic Kinase (ALK)-Positive Advanced

  • Lung Cancer
  • Non-Small Cell Lung Cancer (NSCLC)